tradingkey.logo


tradingkey.logo


Teva Pharmaceutical Industries Ltd

TEVA
29.460USD
+0.320+1.10%
āļ›āļīāļ” 03/25, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
33.87BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
23.92P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Teva Pharmaceutical Industries Ltd āļšāļĢāļīāļĐāļąāļ—

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

āļ‚āđ‰āļ­āļĄāļđāļĨ Teva Pharmaceutical Industries Ltd


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™TEVA
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Teva Pharmaceutical Industries Ltd
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļFeb 06, 2087
āļ‹āļĩāļ­āļĩāđ‚āļ­Francis (Richard D)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™33892
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒDepository Receipt
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Feb 06
āļ—āļĩāđˆāļ­āļĒāļđāđˆ124 Dvora Hanevi'a St.
āđ€āļĄāļ·āļ­āļ‡TEL AVIV-YAFO
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻIsrael
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ6944020
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ97239148213
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.tevapharm.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™TEVA
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļFeb 06, 2087
āļ‹āļĩāļ­āļĩāđ‚āļ­Francis (Richard D)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Teva Pharmaceutical Industries Ltd


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Roberto A. Mignone
Mr. Roberto A. Mignone
Independent Director
Independent Director
--
--
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+42.80%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
--
--
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
--
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Generic products
2.58B
57.54%
AUSTEDO
609.00M
13.59%
Anda
392.00M
8.75%
Other
274.00M
6.12%
AJOVY
169.00M
3.77%
āļ­āļ·āđˆāļ™ āđ†
458.00M
10.22%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
United States
2.48B
55.40%
Europe
1.24B
27.57%
International Markets
558.00M
12.46%
Other
205.00M
4.58%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Generic products
2.58B
57.54%
AUSTEDO
609.00M
13.59%
Anda
392.00M
8.75%
Other
274.00M
6.12%
AJOVY
169.00M
3.77%
āļ­āļ·āđˆāļ™ āđ†
458.00M
10.22%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 21 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Harel Insurance Investments and Financial Services Ltd
3.86%
Phoenix Investment and Finances Ltd
3.53%
Menora Mivtachim Insurance Ltd.
3.38%
Clal Insurance Enterprises Holdings Ltd.
3.21%
Migdal Insurance and Financial Holdings Ltd
3.21%
āļ­āļ·āđˆāļ™ āđ†
82.81%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Harel Insurance Investments and Financial Services Ltd
3.86%
Phoenix Investment and Finances Ltd
3.53%
Menora Mivtachim Insurance Ltd.
3.38%
Clal Insurance Enterprises Holdings Ltd.
3.21%
Migdal Insurance and Financial Holdings Ltd
3.21%
āļ­āļ·āđˆāļ™ āđ†
82.81%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
25.38%
Investment Advisor/Hedge Fund
12.78%
Hedge Fund
6.70%
Insurance Company
6.60%
Sovereign Wealth Fund
3.06%
Research Firm
2.15%
Pension Fund
1.75%
Bank and Trust
0.96%
Family Office
0.91%
āļ­āļ·āđˆāļ™ āđ†
39.71%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 1 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
1170
665.23M
57.84%
-137.26M
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
Harel Insurance Investments and Financial Services Ltd
37.70M
3.29%
+4.31M
+12.90%
Sep 30, 2025
Phoenix Investment and Finances Ltd
41.30M
3.6%
+3.53M
+9.36%
Sep 30, 2025
Menora Mivtachim Insurance Ltd.
38.92M
3.39%
-18.47M
-32.19%
Sep 30, 2025
Clal Insurance Enterprises Holdings Ltd.
31.49M
2.74%
-876.00K
-2.71%
Sep 30, 2025
Migdal Insurance and Financial Holdings Ltd
32.58M
2.84%
+3.90M
+13.58%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
34.92M
3.04%
+1.03M
+3.04%
Sep 30, 2025
Lingotto Investment Management LLP
28.59M
2.49%
+431.87K
+1.53%
Sep 30, 2025
Fidelity Management & Research Company LLC
20.19M
1.76%
-30.45M
-60.13%
Sep 30, 2025
Rubric Capital Management LP
24.65M
2.15%
-1.35M
-5.19%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
iShares MSCI Israel ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™7.76%
VanEck Israel ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™7.5%
VanEck Pharmaceutical ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.79%
First Trust WCM Developing World Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.16%
First Trust WCM International Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.64%
ARK Israel Innovative Technology ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.81%
WealthTrust DBS Long Term Growth ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.42%
WisdomTree International Multifactor Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.77%
iShares Health Innovation Active ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.69%
iShares MSCI Intl Value Factor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.46%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™